Literature DB >> 1587659

Nonsegmental vitiligo: decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation.

M B Abdel-Naser1, W D Ludwig, H Gollnick, C E Orfanos.   

Abstract

Peripheral T-lymphocytes from 16 randomly selected patients with nonsegmental vitiligo were labeled with monoclonal antibodies recognizing T-cell receptor (TCR) alpha/beta, TCR gamma/delta, CD3, CD4, CD8, CD45RA, CD45RO, CD11b, CD11c, CD16, CD56, CD25, CD54, and HLA-DR antigens. In comparison with matched controls, a significant decrease of the CD45RA+ subset (P less than 0.03) together with significant increase of the circulating HLA-DR+ cells (P less than 0.02) was found. No other alterations were detected. These findings may point to some autoimmune phenomena involved in the pathogenesis of the disease. The increased HLA-DR expression indicates the presence of activated peripheral T-cells. Thus, our data provide new and further evidence for T-cell dysregulation in nonsegmental vitiligo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587659     DOI: 10.1111/j.1365-4362.1992.tb03946.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.

Authors:  I C Le Poole; R M van den Wijngaard; W Westerhof; P K Das
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 2.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo.

Authors:  Martin Noël; Claude Gagné; Jean Bergeron; Jean Jobin; Paul Poirier
Journal:  Lipids Health Dis       Date:  2004-05-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.